NASDAQ:JLHL 9 July 2026

July 9, 2026, 3:47 PM EDT. Omnicell (OMCL) has climbed 51.6% in the last year, topping the industry by 72.8% and beating the S&P 500 by 28.4%. The healthcare tech firm's market cap is $1.96 billion with a 4.7% earnings yield, well above the industry's -1%. The company is pushing its Autonomous Pharmacy model and growing by adding new SaaS platforms and acquisitions. Still, macroeconomic headwinds like $12 million in tariff costs and tough competition are squeezing margins. OMCL keeps ramping up R&D and subscription revenue, but investors are watching for signs that growth can hold up under these pressures.